{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-012902","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2026-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.993827+00:00","generated_at":"2026-05-15T08:48:29.163710+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Daré Bioscience FY2025: $24.7M cash, $20.8M equity proceeds; DARE to PLAY revenue expected Q2 2026","bullets":["Cash and cash equivalents $24.7M at Dec 31, 2025; working capital $3.4M.","Received $20.8M net from at-the-market equity program and equity line in 2025.","Non-dilutive funding: $13.6M Gates Foundation, $4.5M ARPA-H, $1.3M NIH in 2025.","SG&A $8.8M (down from $9.2M in 2024); R&D $5.5M (down from $14.3M); contra-R&D $16.4M from grants.","Expects DARE to PLAY product revenue and Flora Sync LF5 consumer revenue to begin Q2 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-012902","json":"https://secwatch.observer/filing/0001493152-26-012902.json","markdown":"https://secwatch.observer/filing/0001493152-26-012902.md","text":"https://secwatch.observer/filing/0001493152-26-012902.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226012902/0001493152-26-012902-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226012902/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:48:29.163710+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9ebe0f3574da52de843096d97d8e03e7c5b410c7","claim":"Dare Bioscience, Inc. reported financial results for the year ended December 31, 2025.","evidence_excerpt":"On March 26, 2026, Daré Bioscience, Inc. (the “Company”) issued a press release announcing its financial results for the year ended December 31, 2025, a copy of which is furnished as Exhibit 99.1 to this report.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226012902/0001493152-26-012902-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2025"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}